Regeneron To Report Third Quarter 2019 Financial And Operating Results And Host Conference Call And Webcast On November 5, 2019

Tarrytown, N.Y., (STL.News) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its…

US District Court Invalidates Amgen Patent Claims Targeting PCSK9

Court rules in favor of Regeneron and Sanofi in ongoing Praluent® (alirocumab) patent litigation (STL.News) –…